Probing the Conformation of the Human T-Lymphotropic Virus I Envelope Protein Complex with Monoclonal Antibodies

References

1. Baba E., Nakamura M., Tanaka Y., Kuroki M., Itoyama Y., Nakano S., Niho Y. 1993; Multiple neutralising B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-I). Joumal of Immunology 151:1013–1024
   [Google Scholar]
2. Carr C. M., Kim P. S. 1993; A spring loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823–832
   [Google Scholar]
3. Carrington C. V. F., Weiss R. A., Schulz T. F. 1994; A truncated HTLV-I envelope protein, lacking the hydrophobic membrane anchor domain, is associated with cellular membranes and virions. Virology 202:61–69
   [Google Scholar]
4. Chen S. S., Lee C. N., Lee W. R., McIntosh K., Lee T. H. 1993; Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. Journal of Virology 67:3615–3619
   [Google Scholar]
5. Delwart E. L., Mosialos G., Gilmore T. 1990; Retroviral envelope glycoproteins contain a ‘leucine zipper’-like repeat. AIDS Research and Human Retroviruses 6:703–706
   [Google Scholar]
6. Dubay J. W., Roberts S. J., Brody B., Hunter E. 1992; Mutations in the leucine zipper of the human immunodeficiency virus type I transmembrane glycoprotein affect fusion and infectivity. Journal of Virology 66:4748–4756
   [Google Scholar]
7. Hattori S., Kiyokawa T., Imagawa K., Shimizu F., Hashimura E., Seiki M., Yoshida M. 1984; Identification of gag and env gene products of human T-cell leukemia virus (HTLV). Virology 136:338–347
   [Google Scholar]
8. Kuroki M., Nakamura M., Itoyama Y., Tanaka Y., Shiraki H., Baba E., Esaki T., Tatsumoto T., Nagafuchi S., Nakano S., Niho Y. 1992; Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1. Journal of Immunology 149:940–948
   [Google Scholar]
9. Lee T. H., Coligan J. E., Homma T., McLane M. F., Tachibana N., Essex M. 1984; Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. Proceedings of the National Academy of Sciences, USA 81:3856–3860
   [Google Scholar]
10. Matsushita S., Robert-Guroff M., Trepel J., Cossman J., Mitsuya H., Broder S. 1986; Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I. Proceedings of the National Academy of Sciences, USA 83:2672–2676
    [Google Scholar]
11. Moore J. P. 1990; Simple methods for monitoring HIV-1 and HIV-2 gp!20 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25 fold lower affinity than HIV-1 for soluble CD4. AIDS 4:297–305
    [Google Scholar]
12. Moore J. P., Wallace L. A., Follett E. A., McKeating J. A. 1989; Anenzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS 3:155–163
    [Google Scholar]
13. Paine E., Gu R., Ratner L. 1994; Structure and expression of the human T-cell leukemia virus type 1 envelope protein. Virology 199:331–338
    [Google Scholar]
14. Palker T. J., Tanner M. E., Scearce R. M., Streilein R. D., Clark M. E., Haynes B. F. 1989; Mapping of immunogenic regions of human T-cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with encoded synthetic peptides and a monoclonal antibody to gp46. Journal of Immunology 142:971–978
    [Google Scholar]
15. Paul N. L., Marsh M., McKeating J. A., Schulz T. F., Liljestrom P., Garoff H., Weiss R. A. 1993; Expression of HIV-1 envelope glycoprotein by Semliki Forest virus vectors. AIDS Research and Human Retroviruses 9:963–970
    [Google Scholar]
16. Pique C., Pham D., Tursz T., Dokhelar M. C. 1992; Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation. Journal of Virology 66:906–913
    [Google Scholar]
17. Ralston S., Hoeprich P., Akita R. 1989; Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I. Journal of Biological Chemistry 264:16343–16346
    [Google Scholar]
18. Sattentau Q. J., Zolla-Pazner S., Poignard P. 1995; Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 206:713–717
    [Google Scholar]
19. Tanaka Y., Tanaka R., Terada E., Koyanagi Y., Miyano-Kurosaki N., Yamamoto N., Baba E., Nakamura M., Shida H. 1994; Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. Journal of Virology 68:6323–6331
    [Google Scholar]
20. Wild C., Oas T., McDanal C., Bolognesi D., Matthews T. 1992; A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proceedings of the National Academy of Sciences, USA 89:10537–10541
    [Google Scholar]